These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17567851)

  • 21. Application of emerging technologies in toxicology and safety assessment: regulatory perspectives.
    Leighton JK
    Int J Toxicol; 2005; 24(3):153-5. PubMed ID: 16040567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic toxicology in the 21st century: reflections and future directions.
    Mahadevan B; Snyder RD; Waters MD; Benz RD; Kemper RA; Tice RR; Richard AM
    Environ Mol Mutagen; 2011 Jun; 52(5):339-54. PubMed ID: 21538556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Collaborative Systems Biology Projects for the Military Medical Community.
    Zalatoris JJ; Scheerer JB; Lebeda FJ
    Mil Med; 2017 Sep; 182(9):e1802-e1809. PubMed ID: 28885940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicogenomics and systems toxicology: aims and prospects.
    Waters MD; Fostel JM
    Nat Rev Genet; 2004 Dec; 5(12):936-48. PubMed ID: 15573125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An FDA perspective on the nonclinical use of the X-Omics technologies and the safety of new drugs.
    Jacobs A
    Toxicol Lett; 2009 Apr; 186(1):32-5. PubMed ID: 18809476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clearing the standards landscape: the semantics of terminology and their impact on toxicogenomics.
    Burgoon LD
    Toxicol Sci; 2007 Oct; 99(2):403-12. PubMed ID: 17483496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxicogenomics: transcription profiling for toxicology assessment.
    Zhou T; Chou J; Watkins PB; Kaufmann WK
    EXS; 2009; 99():325-66. PubMed ID: 19157067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrating omic technologies into aquatic ecological risk assessment and environmental monitoring: hurdles, achievements, and future outlook.
    Van Aggelen G; Ankley GT; Baldwin WS; Bearden DW; Benson WH; Chipman JK; Collette TW; Craft JA; Denslow ND; Embry MR; Falciani F; George SG; Helbing CC; Hoekstra PF; Iguchi T; Kagami Y; Katsiadaki I; Kille P; Liu L; Lord PG; McIntyre T; O'Neill A; Osachoff H; Perkins EJ; Santos EM; Skirrow RC; Snape JR; Tyler CR; Versteeg D; Viant MR; Volz DC; Williams TD; Yu L
    Environ Health Perspect; 2010 Jan; 118(1):1-5. PubMed ID: 20056575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development.
    Blomme EA; Yang Y; Waring JF
    Toxicol Lett; 2009 Apr; 186(1):22-31. PubMed ID: 18996174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxicogenomic profiling of chemically exposed humans in risk assessment.
    McHale CM; Zhang L; Hubbard AE; Smith MT
    Mutat Res; 2010 Dec; 705(3):172-83. PubMed ID: 20382258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicogenomics in Environmental Science.
    Brinke A; Buchinger S
    Adv Biochem Eng Biotechnol; 2017; 157():159-186. PubMed ID: 27864593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Where is toxicology headed in the future?
    Guengerich FP
    Drug Metab Rev; 2004 Oct; 36(3-4):475-86. PubMed ID: 15554230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of toxicogenomics in drug safety evaluation: Current status and an industry perspective.
    Vahle JL; Anderson U; Blomme EAG; Hoflack JC; Stiehl DP
    Regul Toxicol Pharmacol; 2018 Jul; 96():18-29. PubMed ID: 29679677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Where will genetic toxicology testing be in 30 years' time? Summary report of the 25th Industrial Genotoxicity Group Meeting, Royal Society of Medicine, London, November 9, 2011.
    Ellis P; Fowler P; Booth E; Kidd D; Howe J; Doherty A; Scott A
    Mutagenesis; 2014 Jan; 29(1):73-7. PubMed ID: 24334751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular, clinical and environmental toxicology. Preface.
    Luch A
    EXS; 2009; 99():XI-XIV. PubMed ID: 19157055
    [No Abstract]   [Full Text] [Related]  

  • 36. Development of novel tools for the in vitro investigation of drug-induced liver injury.
    Jiang J; Wolters JE; van Breda SG; Kleinjans JC; de Kok TM
    Expert Opin Drug Metab Toxicol; 2015; 11(10):1523-37. PubMed ID: 26155718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxicogenomic analysis methods for predictive toxicology.
    Maggioli J; Hoover A; Weng L
    J Pharmacol Toxicol Methods; 2006; 53(1):31-7. PubMed ID: 16236530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxicogenomics: regulatory perspective on current position.
    Battershill JM
    Hum Exp Toxicol; 2005 Jan; 24(1):35-40. PubMed ID: 15727054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemical effects in biological systems--data dictionary (CEBS-DD): a compendium of terms for the capture and integration of biological study design description, conventional phenotypes, and 'omics data.
    Fostel J; Choi D; Zwickl C; Morrison N; Rashid A; Hasan A; Bao W; Richard A; Tong W; Bushel PR; Brown R; Bruno M; Cunningham ML; Dix D; Eastin W; Frade C; Garcia A; Heinloth A; Irwin R; Madenspacher J; Merrick BA; Papoian T; Paules R; Rocca-Serra P; Sansone AS; Stevens J; Tomer K; Yang C; Waters M
    Toxicol Sci; 2005 Dec; 88(2):585-601. PubMed ID: 16150882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deciphering diseases and biological targets for environmental chemicals using toxicogenomics networks.
    Audouze K; Juncker AS; Roque FJ; Krysiak-Baltyn K; Weinhold N; Taboureau O; Jensen TS; Brunak S
    PLoS Comput Biol; 2010 May; 6(5):e1000788. PubMed ID: 20502671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.